01053nas a2200217   4500000000100000008004100001653003200042653002500074653002800099653002300127100001200150700001300162700001300175700001500188700001300203700001200216245020900228050001500437520036900452022001400821       2016                            d10aImmunotherapy (MIP vaccine)10aClinical improvement10aChemotherapy (WHO- MDT)10aBorderline leprosy1 aKamal R1 aPathak V1 aKumari A1 aNatrajan M1 aKatoch K1 aKar H K00aAddition of Mycobacterium indicus pranii (MIP) vaccine as an immunotherapeutic with standard chemotherapy in borderline leprosy: A double blind study to assess clinical improvement (A preliminary report).  aKAMAL 20163 a<p>The response of leprosy patients to chemotherapy (WHO-Multi Drug Therapy) though generally good and predictable, exhibits variations in a section of cases. Some cases show a dramatic response while others show a slower response such variations are a reflection of the immune status of the host. This article is protected by copyright. All rights reserved.</p>
  a1365-2133